Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

New Indicator for Pituitary Adenoma/PitNET Classification—SF-1

Introduction:In 2017, the WHO established a clearer classification for primary adenohypophyseal tumors based on their cell lineage orig...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

IHC Master’s Diary: Antibody Selection

Introduction:We often use antibodies in daily experiments, but we often don't know how to choose them. Are monoclonal antibodies better...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Companion Diagnostics Facilitate Immunotherapy, But What Is Immunotherapy?

Introduction:In today's society, cancer is becoming increasingly prevalent, and many people fear it. At this time, immunotherapy has em...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Tumor Talk: Can Inflammation Turn into Cancer?

Introduction:According to a report from the International Agency for Research on Cancer, 1/6 of cancers are caused by bacterial or vira...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

IHC Technique Guide: Tips to Prevent Tissue Detachment

Preface:"Tissue detachment" is something every technician wants to avoid, as it means the work of one or even two days goes down the dr...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Application of Immunohistochemistry in the Classification of Salivary Gland Tumors (Part 1)

Author Introduction:Zhang Renya · ProfessorDirector of the Pathology Center and Director of the Molecular Pathology Laboratory at the A...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Do you know what companion diagnostics are?

Introduction:Companion diagnostics is an in vitro diagnostic technology associated with targeted drugs. It primarily screens for the op...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

A Tree of Subtle Flowers Occasionally Brightens: BCOR as an IHC Surrogate Marker for Genomic Alterations in Soft Tissue and Bone Tumors

Introduction:In recent years, new immunohistochemical markers developed based on molecular genetic alterations in soft tissue and bone ...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

Immunohistochemical Diagnosis of Renal Epithelial Tumors (Part 1)

Author Introduction:Professor Zhang Renya, Chief Physician, Master's Supervisor■ Director of the Department of Pathology, Affiliated Ho...
Continue reading
06 2 月
Hotspot Focus
Posted by author-avatar fzmaixinswy@163.com
6 2 月, 2026
0

p53 Antibody Immunohistochemical Expression Pattern

Brief Overview of p53Tp53The gene is a tumor suppressor gene located on the short arm of chromosome 17 (17p13.1).Tp53The tumor suppress...
Continue reading
  • «
  • ‹
  • 9
  • 10
  • 11
  • 12
  • 13
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar